Effects of angiotensin-converting enzyme inhibitor on peripheral skeletal muscle dysfunction in emphysematous rats Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin Source: Eur Respir J 2008; 31: 363-371 Year: 2008
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004
Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 196s Year: 2001
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Source: Eur Respir J 2008; 31: 611-617 Year: 2008
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1702638; 10.1183/13993003.02638-2017 Year: 2018
The influence of angiotensin-converting enzyme (ACE) genotype on the development of severe perinatal asphyxia in the neonates Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interstitial pulmonary fibrosis in Iranian population Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Angiotensin-converting enzyme genotype modulates pulmonary artery pressure in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009